Stanex Drugs And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.75 Cr
as on 30-09-2024
- Paid Up Capital ₹ 1.75 Cr
as on 30-09-2024
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 23.67 Cr
as on 30-09-2024
- Satisfied Charges ₹ 5.45 Cr
as on 30-09-2024
- Revenue -17.74%
(FY 2023)
- Profit 27.69%
(FY 2023)
- Ebitda 48.79%
(FY 2023)
- Net Worth 17.85%
(FY 2023)
- Total Assets -47.11%
(FY 2023)
About Stanex Drugs And Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.75 Cr and a paid-up capital of Rs 1.75 Cr.
The company currently has active open charges totaling ₹23.67 Cr. The company has closed loans amounting to ₹5.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhagavan Kamireddy, Yella Kamireddy, Sridevi Kamireddy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239TG2004PTC044988
- Company No.
044988
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Stanex Drugs And Chemicals Private Limited offer?
Stanex Drugs And Chemicals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Anti Infective Drugs & Medicines, Antibacterial Drugs, Common Disease Medicines, Skin Lightening Drugs, Antacid Drugs, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Stanex Drugs And Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhagavan Kamireddy  | Managing Director | 28-Dec-2004 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yella Kamireddy | Director | 28-Dec-2004 | Current |
| Sridevi Kamireddy | Director | 28-Dec-2004 | Current |
| Nitya Kamireddy | Director | 29-Apr-2023 | Current |
Financial Performance of Stanex Drugs And Chemicals.
Stanex Drugs And Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.74% decrease. The company also saw a substantial improvement in profitability, with a 27.69% increase in profit. The company's net worth Soared by an impressive increase of 17.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stanex Drugs And Chemicals?
In 2023, Stanex Drugs And Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Stanex Breeding Farms Private LimitedActive 15 years 8 monthsBhagavan Kamireddy and Sridevi Kamireddy are mutual person
- Stanzen Life Sciences Private LimitedActive 6 years 3 months
Bhagavan Kamireddy and Nitya Kamireddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Mar 2022 | ₹2.58 M | Open |
Others Creation Date: 23 Sep 2021 | ₹20.64 Cr | Open |
Others Creation Date: 29 Apr 2020 | ₹6.83 M | Open |
How Many Employees Work at Stanex Drugs And Chemicals?
Stanex Drugs And Chemicals has a workforce of 46 employees as of Sep 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stanex Drugs And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stanex Drugs And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
